Abstract
Background: Autoantibodies directed to centromere protein F were first reported in 1993 and their association with malignancy has been well documented. Case: We present the case of a 48-year-old Caucasian female with a BRCA1 gene mutation associated with bilateral breast cancer. Antinuclear autoantibody immunofluorescence performed for workup of possible inflammatory arthropathy showed a high titre cell cycle related nuclear speckled pattern, with subsequent confirmation by addressable laser bead immunoassay of the target antigen as an immunodominant epitope at the C-terminus of centromere protein F. Conclusion: Here we review the current literature on centromere protein F, its association with breast cancer and present the first case of this antibody being identified in a person with a BRCA1 gene mutation.
| Original language | English |
|---|---|
| Article number | 84 |
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | BMC Research Notes |
| Volume | 9 |
| DOIs | |
| Publication status | Published - 11 Feb 2016 |
| Externally published | Yes |
Bibliographical note
Copyright the Author(s) 2016. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.Keywords
- ALBIA
- antinuclear antibody
- BRCA1
- CENP-F
- malignancy
Fingerprint
Dive into the research topics of 'Autoantibodies directed to centromere protein F in a patient with BRCA1 gene mutation'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver